Education
About Us
Working with TipRanks
Follow Us
VentriPoint Diagnostics (TSE:VPT)
:VPT
VPT Stock Chart & Stats
C$0.10
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.10
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.20
Previous CloseN/A
Volume32.00K
Average Volume (3M)116.82K
Market Cap
C$17.61M
Enterprise ValueC$23.15M
Total Cash (Recent Filing)C$248.82K
Total Debt (Recent Filing)C$2.22M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding167,704,010
10 Day Avg. Volume106,226
30 Day Avg. Volume116,819
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-5.31
Price to Sales (P/S)166.31
P/FCF Ratio-4.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VentriPoint Diagnostics News
VPT FAQ
What was VentriPoint Diagnostics’s price range in the past 12 months?
VentriPoint Diagnostics lowest stock price was C$0.07 and its highest was C$0.20 in the past 12 months.
What is VentriPoint Diagnostics’s market cap?
VentriPoint Diagnostics’s market cap is C$17.61M.
When is VentriPoint Diagnostics’s upcoming earnings report date?
VentriPoint Diagnostics’s upcoming earnings report date is Nov 26, 2025 which is in 37 days.
How were VentriPoint Diagnostics’s earnings last quarter?
VentriPoint Diagnostics released its earnings results on Aug 29, 2025. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is VentriPoint Diagnostics overvalued?
According to Wall Street analysts VentriPoint Diagnostics’s price is currently Overvalued.
Does VentriPoint Diagnostics pay dividends?
VentriPoint Diagnostics does not currently pay dividends.
What is VentriPoint Diagnostics’s EPS estimate?
VentriPoint Diagnostics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VentriPoint Diagnostics have?
VentriPoint Diagnostics has 167,704,010 shares outstanding.
What happened to VentriPoint Diagnostics’s price movement after its last earnings report?
VentriPoint Diagnostics reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of VentriPoint Diagnostics?
Currently, no hedge funds are holding shares in TSE:VPT
VentriPoint Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.25%
12-Months-Change
Fundamentals
Return on Equity
207.08%
Trailing 12-Months
Asset Growth
-21.46%
Trailing 12-Months
Company Description
VentriPoint Diagnostics
VentriPoint Diagnostics (VPT) is a medical device company specializing in developing advanced imaging solutions for cardiac diagnostics. The company is focused on improving the assessment of heart function using its proprietary technology that enables accurate and efficient three-dimensional visualization of the heart. VentriPoint's core product, the VMS+ system, offers a non-invasive, cost-effective alternative to traditional imaging methods, aiming to enhance patient care and streamline the diagnostic process in cardiology.
Technical Analysis
Aurora Spine
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
Profound Medical
―
Theralase Technologies
―
Options Prices
Currently, No data available
---